Preliminary Opinions
Hexyl Salicylate: Preliminary SCCS opinion
On 9 November 2023, the SCCS published the preliminary opinion on Hexyl Salicylate used in cosmetic products. The deadline for comments was set for 12 January 2024.
On average, 70% of our news is listed, while updates from the last 30 days are not visible.
To get access to all content and services,
Start your Free Trial or Discover our plans.
Already a Premium member? Sign In
On 9 November 2023, the SCCS published the preliminary opinion on Hexyl Salicylate used in cosmetic products. The deadline for comments was set for 12 January 2024.
On 4 July 2023, the SCCS published the preliminary opinion on Water-soluble Zinc salts in oral cosmetic products. The deadline for comments was set for 8 September 2023.
On 13 June 2023, the SCCS published the preliminary opinion on the fragrance ingredient “Benzyl Salicylate” included in the priority list of 28 potential Endocrine Disruptors (EDs). The deadline for comments was set for 4 August 2023.
On 8 June 2023, the SCCS published the preliminary opinion on Butylparaben, with CAS No. 94-26-8, EC No. 202-318-7. The deadline for comments was set for 21 August 2023.
On 8 June 2023, the SCCS published the preliminary opinion on Methylparaben, with CAS No. 99-76-3, EC No. 202-785-7. The deadline for comments was set for 21 August 2023.
On 16 May 2023, the SCCS published the preliminary scientific advice on the safety of children’s exposure to Methyl Salicylate (methyl 2-hydroxybenzoate, CAS/EC No. 119-36-8/204-317-7) as used in cosmetic products. The deadline for comments was set for 19 June 2023.
On 24 April 2023, the SCCS published the preliminary opinion on Fullerenes, Hydroxylated Fullerenes, and hydrated forms of Hydroxylated Fullerenes (nano), with CAS/EC No. 99685-96-8/628-630-7, 11538-22-7/-, 182024-48 42-6/-. The deadline for comments was set for 12 June 2023.
On 4 April 2023, the SCCS published the preliminary opinion on Silver Zinc Zeolite with (CAS No. 130328-20-0, EC No. 603-404-0). The deadline for comments was set for 5 June 2023.
On 11 January 2023, the SCCS published the preliminary opinion on Hydroxyapatite (nano), with CAS no: 1306-06-5. The deadline for comments was set for 1 March 2023.
On 15 December 2022, the SCCS published the preliminary opinion on Salicylic Acid with CAS no “69-72-7”. The deadline for comments was set for 17 February 2023.